Line Wergeland

Publikasjonar

• Bioingeniører må være med å utdanne morgendagens bioingeniører - med hvordan rekrutterer vi dem?

  Elisabeth Ersvær, Anette Christensen Lie-Jensen, Ranjan Chrisanthar, Inger-Lise F. Neslein, Ann Iren Solli, Bente Alm (2025)
  Bioingeniøren 2025 s. 26-29

• Skikkethetsvurdering av bioingeniørstudenter – et felles ansvar

  Line Wergeland, Jeanette Haukeland Bakke, Lena Seim Grønningsæter (2025)
  Bioingeniøren 2025 ;Volum 60. s. 16-21

• Paneldebatt Språkutfordringer i skikkethetsvurdering

  Line Wergeland, Trude Bukve, Erik Andvik, Ingrid Gilje Heiberg (2023)

• Teaching and Learning in clinical practice and laboratory training in Europe

  Line Wergeland, Gry Sjøholt (2023)

• UHR sier nei! Men vi sier ja!

  Elisabeth Ersvær, Line Wergeland, Hege Smith Tunsjø, Inger-Lise F. Neslein, Anette Christensen Lie-Jensen, Vivian Berg (2023)
  Khrono 2023

• Blended learning in biomedical laboratory science

  Line Wergeland, Gry Sjøholt (2022)

• Vil styrke norsk språkkrav for bioingeniører

  Heidi Andersen, Bente Alm, Vivian Berg, Elisabeth Ersvær, Anette Christensen Lie-Jensen, Inger-Lise F. Neslein (2022)
  Bioingeniøren 2022

• Vil styrke norsk språkkrav for bio­ingeniører

  Heidi Andersen, Bente Alm, Vivian Berg, Elisabeth Ersvær, Anette Christensen Lie-Jensen, Inger-Lise F. Neslein (2022)
  Khrono.no 2022

• Tenk hva de nasjonale fag­organene innen helse og sosial kunne fått til sammen

  Heidi Andersen, Bente Alm, Vivian Berg, Elisabeth Ersvær, Anette Christensen Lie-Jensen, Inger-Lise F. Neslein (2022)
  Khrono.no 2022

• FLT3-ITD mutations in acute myeloid leukaemia – molecular characteristics, distribution and numerical variation

  Caroline Engen, Monica Hellesøy, Tim Grob, Adil Al Hinai, Atle Brendehaug, Line Wergeland (2021)
  Molecular Oncology 2021 ;Volum 15. s. 2300-2317

• Targeted Therapy of FLT3 in Treatment of AML-Current Status and Future Directions

  Caroline Benedicte Nitter Engen, Line Wergeland, Jørn Skavland, Bjørn Tore Gjertsen (2014)
  Journal of Clinical Medicine 2014

• Målrettet behandling av akutt myelogen leukemi - hemmere mot FLT3 og andre kinaser viser vei

  Caroline Benedicte Nitter Engen, Line Wergeland, Bjørn Tore Gjertsen (2013)
  Best Practice 2013

• Expression of TP53 isoforms p53 beta or p53 gamma enhances chemosensitivity in TP53(null) cell lines

  Elisabeth Silden, Sigrun Margrethe Hjelle, Line Wergeland, Andre Sulen, Vibeke Andresen, Jean-Christophe Bourdon (2013)
  PLOS ONE 2013 ;Volum 8.

• Ectopic expression of Flt3 kinase inhibits proliferation and promotes cell death in different human cancer cell lines

  Eystein Oveland, Line Wergeland, Randi Hovland, James Lorens, Bjørn Tore Gjertsen, Kari Espolin Fladmark (2012)
  Cell Biology and Toxicology 2012 ;Volum 28. s. 201-212

• Ligand-induced Flt3-downregulation modulates cell death associated proteins and enhances chemosensitivity to idarubicin in THP-1 acute myeloid leukemia cells

  Eystein Oveland, Bjørn Tore Gjertsen, Line Wergeland, Frode Selheim, Kari Espolin Fladmark, Randi Hovland (2009)
  Leukemia Research 2009 ;Volum 33. s. 276-287

• Camptothecin and khat (Catha edulis Forsk.) induced distinct cell death phenotypes involving modulation of c-FLIPL, Mcl-1, procaspase-8 and mitochondrial function in acute myeloid leukemia cell lines

  Therese Bredholt, Elisabeth Anne Okumu Dimba, Hanne Hagland, Line Wergeland, Jørn Skavland, Kjell O. Fossan (2009)
  Molecular Cancer 2009 ;Volum 8.

• FLT3 internal tandem duplication involving its libiquitin dependent endocytosis motif suspend modulation by HDM2 and are associated with inferior survival in AML

  Line Wergeland, Eystein Oveland, Gry Sjøholt, Siv Lise Bedringaas, Randi Hovland, Øystein Bruserud (2008)
  Haematologica 2008 ;Volum 93. s. 10-10

• Flt3 mutations in proximity to an ubiquitin dependent endocytosis motif suspend its Hdm2 modulation

  Line Wergeland, Eystein Oveland, Gry Sjøholt, Siv Lise Bedringaas, Randi Hovland, Øystein Bruserud (2007)
  Blood 2007 ;Volum 110.

• Pre-apoptotic response to therapeutic DNA damage involves protein modulation of Mcl-1, Hdm2 and Flt3 in acute myeloid leukemia cells

  Line Wergeland, Gry Sjøholt, Ingvild Haaland, Randi Hovland, Øystein Bruserud, Bjørn Tore Gjertsen (2007)
  Molecular Cancer 2007 ;Volum 6.

• Flt3 receptor tyrosine kinase in AML and its modulation of the p53/Hdm2/Bcl-2 pathway

  Line Wergeland, Bjørn Tore Gjertsen, Øystein Bruserud (2007)
  Universitetet i Bergen

• Flt3 Mutations in Proximity to an Ubiquitin Dependent Endocytosis Motif Suspend Its Hdm2 Modulation

  Line Wergeland, Eystein Oveland, Gry Sjøholt, Siv Lise Bedringaas, R Hovland, Øystein Bruserud (2007)

• Proteomics approaches to elucidate oncogenic tyrosine kinase signaling in myeloid malignancies

  Eystein Oveland, Kari Espolin Fladmark, Line Wergeland, Bjørn Tore Gjertsen, Randi Hovland (2006)
  Current Pharmaceutical Biotechnology 2006 ;Volum 7. s. 185-198

• Proteomics in acute myelogenous leukaemia (AML): Methodological strategies-and identification of protein targets for novel antileukaemic therapy

  Gry Sjøholt, Nina Ånensen, Line Wergeland, Emmet Martin McCormack, Øystein Bruserud, Bjørn Tore Gjertsen (2005)
  Current Drug Targets 2005 ;Volum 6. s. 631-646

• In vitro crosstalk between fibroblasts and native human acute myelogenous leukemia (AML) blasts via local cytokine networks results in increased proliferation and decreased apoptosis of AML cells as well as increased levels of proangiogenic Interleukin 8

  Anita Ryningen, Line Wergeland, Nils Glenjen, Bjørn Tore Gjertsen, Øystein Bruserud (2005)
  Leukemia Research 2005 ;Volum 29. s. 185-196

• Proteomics in acute myelogenous leukaemia (AML): methodological strategies and identification of protein targets for novel antileukaemic therapy

  Gry Sjøholt, Nina Ånensen, Line Wergeland, Emmet Martin McCormack, Øystein Bruserud, Bjørn Tore Gjertsen (2005)
  Current Drug Targets 2005 ;Volum 6. s. 631-646

• Osteoblasts increase proliferation and release of pro-angiogenic interleukin 8 by native human acute myelogenous leukemia blasts

  Øystein Bruserud, Anita Ryningen, Line Wergeland, Nils Glenjen, Bjørn Tore Gjertsen (2004)
  Haematologica 2004 ;Volum 89. s. 391-402

• Ionizing irradiation induces Bcl-2 sensitive HDM2 degradation through ubiquitination in cancer cells

  Bjørn Tore Gjertsen, Anne Paulus Døskeland, Line Wergeland, K. Spurgers, M. Cascallo, T. Honda (2004)

• Flt3 and HDM2 are reciprocally regulated through phosphorylation and ubiquitination in acute myelogenous leukaemia

  Line Wergeland, Eystein Oveland, Randi Hovland, Øystein Bruserud, Anne Paulus Døskeland, Bjørn Tore Gjertsen (2004)

• Flt3-mediated signaling in human acute myelogenous leukemia (AML) blasts: a functional characterization of Flt3-ligand effects in AML cell populations with and without genetic Flt3 abnormalities

  Øystein Bruserud, Randi Hovland, Line Wergeland, Tien-Sheng Huang, Bjørn Tore Gjertsen (2003)
  Haematologica 2003

• The angioregulatory phenotype of native human acute myelogenous leukemia cells: influence of karyotype, Flt3 abnormalities and differentiation status

  Nils Glenjen, Randi Hovland, Line Wergeland, Øystein Wendelbo, Peter Ernst, Øystein Bruserud (2003)
  European Journal of Haematology 2003